Product Images Naloxone Hydrochloride

This is a description of a medicine in a single-dose vial. The National Drug Code (NDC) is 36000-308-01 and it is for prescription use only. The medicine should be protected from light and any unused portion should be discarded. It was manufactured in Taiwan for Baxter Healthcare Corporation in Illinois, USA. The medicine may be administered intravenously, intramuscularly or subcutaneously, and the vial has a volume of 1mL. The expiration date is February 26th, 2021.*

This is a description of a medication labeled as Injection, USP with 4 mg/mL concentration. It is intended to be used for Intravenous, Intramuscular or Subcutaneous administration, and it is recommended to protect from light. This medication comes in 10 single-dose vials. It is a sterile and nonpyrogenic solution made by Baxter. The code M5081-02 and NDC 36000-308-10 are provided for identification purposes. The medication comprises naloxone hydrochloride, sodium chloride, and hydrochloric acid for pH adjustment, and it has a tonicity of 0.31 mOsmol/mL (calc.) and a pH of 3.0-10.6. The insert provides information on the usual dosage, and the medication should be kept at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F) as per the USP controlled room temperature instruction.*

This is a description of a medication with the NDC code 36000-308-10. It is a sterile, nonpyrogenic solution that comes in 10 single-dose vials of 1 mL each. The medication can be given intravenously, intramuscularly or subcutaneously. The manufacturer is Baxter, and it should be protected from light until it is ready for use. Unused portions should be discarded. The medication was made in Taiwan and is being distributed by Baxter Healthcare Corporation in Deerfield, IL.*